athenahealth (ATHN) Lifted to “Sell” at BidaskClub

BidaskClub upgraded shares of athenahealth (NASDAQ:ATHN) from a strong sell rating to a sell rating in a research note released on Saturday.

A number of other research firms have also commented on ATHN. Royal Bank of Canada reaffirmed a hold rating and set a $152.00 price target on shares of athenahealth in a research report on Friday, February 2nd. SunTrust Banks raised their price target on athenahealth to $180.00 and gave the stock a buy rating in a research report on Monday, February 5th. Piper Jaffray Companies reaffirmed a buy rating and set a $160.00 price target on shares of athenahealth in a research report on Friday. Deutsche Bank assumed coverage on athenahealth in a research report on Friday, December 8th. They set a hold rating and a $145.00 price target on the stock. Finally, Citigroup assumed coverage on athenahealth in a research report on Thursday, January 4th. They set a neutral rating on the stock. Three research analysts have rated the stock with a sell rating, sixteen have given a hold rating and seven have given a buy rating to the company. The stock presently has an average rating of Hold and an average target price of $144.23.

Shares of athenahealth (ATHN) opened at $138.82 on Friday. The company has a market capitalization of $5,566.40, a PE ratio of 82.14, a PEG ratio of 2.93 and a beta of 1.35. The company has a current ratio of 1.84, a quick ratio of 1.84 and a debt-to-equity ratio of 0.32. athenahealth has a 1 year low of $95.01 and a 1 year high of $158.66.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, February 1st. The health services provider reported $1.11 EPS for the quarter, topping the Zacks’ consensus estimate of $0.63 by $0.48. The company had revenue of $329.20 million for the quarter, compared to analyst estimates of $319.64 million. athenahealth had a return on equity of 9.21% and a net margin of 4.35%. athenahealth’s revenue was up 14.2% compared to the same quarter last year. During the same quarter last year, the firm posted $0.62 earnings per share. research analysts forecast that athenahealth will post 2.29 EPS for the current year.

In other athenahealth news, CEO Jonathan Bush sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $145.00, for a total value of $3,625,000.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $132.97, for a total value of $106,376.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 98,703 shares of company stock valued at $13,487,150. Corporate insiders own 3.20% of the company’s stock.

A number of hedge funds have recently bought and sold shares of the business. BlackRock Inc. grew its stake in athenahealth by 1.4% in the fourth quarter. BlackRock Inc. now owns 1,661,698 shares of the health services provider’s stock valued at $221,073,000 after purchasing an additional 22,767 shares in the last quarter. Allianz Asset Management GmbH grew its stake in athenahealth by 67.0% in the fourth quarter. Allianz Asset Management GmbH now owns 555,766 shares of the health services provider’s stock valued at $73,939,000 after purchasing an additional 223,006 shares in the last quarter. Jackson Square Partners LLC grew its stake in athenahealth by 1.1% in the fourth quarter. Jackson Square Partners LLC now owns 531,549 shares of the health services provider’s stock valued at $70,717,000 after purchasing an additional 5,811 shares in the last quarter. State Street Corp grew its stake in athenahealth by 2.0% in the second quarter. State Street Corp now owns 512,675 shares of the health services provider’s stock valued at $72,052,000 after purchasing an additional 9,852 shares in the last quarter. Finally, ArrowMark Colorado Holdings LLC grew its stake in athenahealth by 30.1% in the fourth quarter. ArrowMark Colorado Holdings LLC now owns 511,863 shares of the health services provider’s stock valued at $68,098,000 after purchasing an additional 118,411 shares in the last quarter.

TRADEMARK VIOLATION WARNING: “athenahealth (ATHN) Lifted to “Sell” at BidaskClub” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/18/athenahealth-athn-lifted-to-sell-at-bidaskclub.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply